The present bachelor thesis addresses the adaptation of a manual ELISA method for the CA 72-4 tumor marker to the fully automated DRG:HYBRiD-XL® analyzer for immunoassays. Such an immunoassay is available for the CA 72-4 tumor marker. The development process is broken down into production and perfection of all needed reagents, followed by verification as well as validation, and subsequent market introduction.
Studiengang / zentr. Einrichtung:
Biotechnologie / Biopharmazeutische Technologie Bachelor